Risk factors for the development of pulmonary arterial hypertension in systemic sclerosis: a prospective cohort study

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

I am a rheumatologist treating systemic sclerosis, a life threatening illness. A serious complication is high blood pressure in the lungs, or pulmonary arterial hypertension. Unfortunately this problem is often detected too late. My goal is to be able to identify those patients who will develop this condition so that they can access life saving treatment at the earliest possible time in order to improve their quality of life and increase their chance of survival.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2014

Funding Scheme: NHMRC Postgraduate Scholarships

Funding Amount: $87,199.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Rheumatology and Arthritis

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

biomarkers | clinical epidemiology | pulmonary hypertension | scleroderma | screening